HITI
High Tide, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CA
$2.62
+1.95%Year over year
Reported trailing growth
- Revenue
- +27.2%
- EBITDA
- -84.2%
- EBIT
- +96.8%
- EPS
- —
- Free cash flow
- -19.2%
- Operating cash flow
- -15.3%
Forward estimates
Based on analyst estimates
- Revenue
- +10.4%
- EBITDA
- +1256.1%
- EPS
- +133.9%
Three-year CAGR
- Revenue
- +18.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -4.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026